NL Industries (NL) stock prices updated...
 

NL Industries stock price, NL

NL Industries stock chart:



NL Industries close price: 6.5

Stock price forecast:

UP TO +3.38%
Target: 6.72

Total forecasts: 90
Reached: 55 (61.11%)

Total Win: 48.70 (615.85%)

DaysForecastsReached%Reached points%InvestedUnreached%Total%
90915560.44%48.706.77%255.7521.758.50%70.4510.73%
30312374.19%6.663.10%48.50-3.50-7.22%3.161.54%
14151386.67%2.623.00%11.35-1.65-14.54%0.971.13%

Showing 1-10 of 478 items.
Date of ForecastStock PriceTarget PriceForecast Reached Date
2017-02-215.956.412017-02-20
2017-02-205.956.332017-02-20
2017-02-195.956.22017-02-20
2017-02-185.956.222017-02-20
2017-02-176.26.322017-02-20
2017-02-165.956.192017-02-16
2017-02-155.55.772017-02-15
2017-02-145.65.642017-02-15
2017-02-135.65.642017-02-15
2017-02-125.65.762017-02-15

NL Industries latest news:


  • 02/16/2017 11:26:33

    MHI rules out rescue of Toshiba’s nuclear business

    Mitsubishi Heavy Industries highlights differences between groups’ technologies

  • 02/15/2017 16:00:00

    BRIEF-Raven Industries posts Q3 earnings per share $0.16

    * Raven Industries reports strong third quarter fiscal 2017 results

  • 02/14/2017 10:38:24

    Allstate Program Could Bring Insurance Into the F&I Office

    Insurance and financing have traditionally been very separate businesses, but a division of The Allstate Corp. is testing a few pilot programs that could bring the two industries closer together, said Tom Capp, senior vice president of business development for the company’s Answer Financial division. Prime consumers, especially those lookingRead More

  • 02/08/2017 14:36:37

    BRIEF-State Street Corp reports a 6.81 pct passive stake in Polaris Industries

    * State Street Corp reports a 6.81 percent passive stake in polaris industries inc as of Dec. 31, 2016 Source text: (http://bit.ly/2k4GuQM) Further company coverage:

  • 02/07/2017 12:45:59

    Teva CEO exits in ongoing crisis of confidence at drugmaker

    Teva Pharmaceutical Industries was left without a permanent chief executive on Tuesday after Erez Vigodman stepped down, leaving new management to restore confidence in the world's biggest generic drugmaker after a series of missteps.

  • 02/06/2017 15:05:01

    Teva Pharma shares slide on CEO departure

    Teva Pharmaceutical Industries Ltd. share slid in the extended session Monday after the Jerusalem-based drugmaker said Erez Vigodman would step down as chief executive effective immediately. Teva shares declined 1% to $34 after hours. The company said Yitzhak Peterburg, the company's chairman since January 2015, will serve as interim CEO, ceding his role as active chairman in accordance with Israeli law, Teva said. Board member Sol Barer was elected to serve as chairman. Teva said it has started a search for a permanent CEO.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 02/02/2017 16:36:19

    Energy sector could see favor in NAFTA talks -Canada minister

    OTTAWA, Feb 2 (Reuters) - Canada's energy sector could find itself more favored than other industries when it comes time to renegotiating the North American Free Trade Agreement, Canadian Minister of Natural Resources Jim Carr said on Thursday.

  • 02/02/2017 14:46:03

    BRIEF-James Hardie Industries 9-mnth net profit up 8 pct

    * 9-mnth net profit US$ 232.0 million versus US$ 215.6 million

  • 01/30/2017 17:15:18

    Teva shares fall as court invalidates patent infringement claims

    Teva Pharmaceutical Industries Ltd. shares fell in the extended session Monday after a court did not uphold patent infringement claims made by the company. Teva shares fell 10% to $31 after hours. The court sided with Mylan NV , which claimed the patents in question were invalid. Mylan shares rose 0.7% to $36.60. The ruling from the U.S. District Court for the District of Delaware stated that the patents in contention, those covering Teva's multiple sclerosis treatment Copaxone, were not valid. Teva said it plans to appeal the decision. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 12/22/2016 08:55:24

    SEC, DOJ fine Teva Pharmaceutical $519 million to settle foreign bribery charges

    The Securities and Exchange Commission and the Department of Justice jointly fined Teva Pharmaceutical Industries Limited , the largest generic drug manufacturer in the world, $519 million on Thursday to settle parallel civil and criminal charges that it allegedly violated the Foreign Corrupt Practices Act when it paid bribes to foreign government officials in Russia, Ukraine, and Mexico between 2002 and 2012. Teva made more than $214 million in illicit profits, according to the SEC, by bribing officials to increase its market share, obtain regulatory approvals and gain favorable drug purchase and prescription decisions. Teva will enter into a deferred prosecution agreement with the U.S. Department of Justice. The company must also retain an independent corporate monitor for at least three years.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 12/21/2016 14:02:12

    Stocks end with slight losses; Dow falls short of 20,000 yet again

    U.S. stocks closed modestly lower on Wednesday as the rally that has pushed equities to repeated records stalled, keeping the Dow mere points from the 20,000 landmark. The day's losses were slight but broad, with seven of the S&P 500's 11 primary sectors ending lower on the day. Real estate and health care stocks were particular decliners, though the impact of those industries were partially offset by gains in material and energy names. The Dow Jones Industrial Average fell 31 points, or 0.2%, to 19,943.34. The blue-chip index closed at a record on Tuesday. The S&P 500 lost 5.52 points, or 0.2%, to 2,265.27. The Nasdaq Composite Index , which is also coming off a record, ended down 12.5 points, or 0.4%, to close at 5,471.43.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 12/13/2016 19:04:37

    HSBC launches special lending facility for start-ups in China's Pearl River Delta

    HONG KONG (Reuters) - HSBC has launched a $290 million lending facility aimed at technology start-ups and other new industries in China's Pearl River Delta region, intensifying the battle for a slice of a business that is growing despite a slowing economy.

  • 12/07/2016 14:51:19

    Prologis and Western Digital Climb; Pfizer Skids

    Prologis and Western Digital trade higher on Wall Street, while Pfizer and Oxford Industries fall

  • 11/28/2016 14:43:21

    Thor Industries shares rally on robust quarterly earnings

    Shares of Thor Industries Inc. rallied in Monday's extended session after the recreatonal vehicle maker posted quarterly results that soundly beat Wall Street's expectations. Thor reported its fiscal first-quarter earnings rose to $78.7 million, or $1.49 a share, from $50.5 million, or 96 cents a share, a year earlier. Revenue increased 66% to $1.71 billion. Analysts surveyed by FactSet had projected earnings of $1.23 a share and revenue of $1.5 billion. Shares rallied nearly 7% after hours. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 11/27/2016 19:02:51

    Brexit EU trade deals 'should not cherry pick' different sectors

    "Cherry picking" certain industries for EU trade deals could also create "losers", campaigners warn.

  • More trends:

    Noah Holdings Ltd.NOAH | Noble CorporationNE-4.45% | Noble Energy Inc.NBL | Nokia CorporationNOK-11.98% | Nomura Holdings Inc ADRNMR | Noranda Aluminum Holding CorporationNOR | Nord Anglia EducationNORD | Nordic American Offshore LtdNAO | Nordic American Tankers LimitedNAT | NordstromJWN+5.67% |